Common Contracts
1 similar null contracts
Agreement Between a Chromogenic Modified Nijmegen- Bethesda Assay and a Qualitative ELISA test in Detection of Factor VIII Inhibitors in Plasma from Persons with Hemophilia A (PwHA)February 13th, 2018
• An inhibitor response via antibody development to Factor VIII (FVIII) replacement therapies is the most significant complication of hemophilia A treatment today.
